GB1492445A - Immunochemically purified derivatives of human chorionic gonadotropin - Google Patents

Immunochemically purified derivatives of human chorionic gonadotropin

Info

Publication number
GB1492445A
GB1492445A GB19098/75A GB1909875A GB1492445A GB 1492445 A GB1492445 A GB 1492445A GB 19098/75 A GB19098/75 A GB 19098/75A GB 1909875 A GB1909875 A GB 1909875A GB 1492445 A GB1492445 A GB 1492445A
Authority
GB
United Kingdom
Prior art keywords
chorionic gonadotropin
human chorionic
hormone
derivative
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB19098/75A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
All India Institute of Medical Sciences AIIMS
Original Assignee
All India Institute of Medical Sciences AIIMS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by All India Institute of Medical Sciences AIIMS filed Critical All India Institute of Medical Sciences AIIMS
Publication of GB1492445A publication Critical patent/GB1492445A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB19098/75A 1974-10-14 1975-05-07 Immunochemically purified derivatives of human chorionic gonadotropin Expired GB1492445A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2287/CAL/74A IN140168B (en:Method) 1974-10-14 1974-10-14

Publications (1)

Publication Number Publication Date
GB1492445A true GB1492445A (en) 1977-11-16

Family

ID=11087405

Family Applications (1)

Application Number Title Priority Date Filing Date
GB19098/75A Expired GB1492445A (en) 1974-10-14 1975-05-07 Immunochemically purified derivatives of human chorionic gonadotropin

Country Status (3)

Country Link
BE (1) BE831786A (en:Method)
GB (1) GB1492445A (en:Method)
IN (2) IN140168B (en:Method)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470773A1 (en:Method) * 1979-11-28 1981-06-12 Pasteur Institut
FR2498192A2 (fr) * 1981-01-22 1982-07-23 Pasteur Institut Nouveau compose polypeptidique thiole provenant d'un fragment de la toxine tetanique, son procede d'obtention et ses applications
EP0117934A1 (en) * 1983-03-04 1984-09-12 The Ohio State University Antigenic modification of polypeptides
EP0178841A3 (en) * 1984-10-11 1987-05-27 University Of Southern California Intragonadal regulatory protein
US4780312A (en) * 1985-06-04 1988-10-25 National Institute Of Immunology Birth control vaccine
EP0326111A3 (en) * 1988-01-29 1989-12-27 New York Blood Center, Inc. Peptide derivatives rendered immunogenic when administered with alum as an adjuvant

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0030496B1 (fr) * 1979-11-28 1983-07-13 Institut Pasteur Composé polypeptidique thiolé provenant d'un fragment de la toxine tétanique, son procédé d'obtention et ses applications
FR2470773A1 (en:Method) * 1979-11-28 1981-06-12 Pasteur Institut
US4479940A (en) * 1981-01-22 1984-10-30 Institut Pasteur Thiolated polypeptide compound derived from a tetanus toxin fragment, the process for its obtention and its applications
EP0057140A3 (en) * 1981-01-22 1982-08-25 Pasteur Institut Thiolated polypeptidic compound from a tetanic toxin fragment, process for its production and its applications
FR2498192A2 (fr) * 1981-01-22 1982-07-23 Pasteur Institut Nouveau compose polypeptidique thiole provenant d'un fragment de la toxine tetanique, son procede d'obtention et ses applications
EP0117934A1 (en) * 1983-03-04 1984-09-12 The Ohio State University Antigenic modification of polypeptides
WO1984003443A1 (en) * 1983-03-04 1984-09-13 Univ Ohio State Antigenic modification of polypeptides
GB2146646A (en) * 1983-03-04 1985-04-24 Univ Ohio State Antigenic modification of polypeptides
EP0213391A3 (en) * 1983-03-04 1989-02-01 The Ohio State University Antigenic modification of polypeptides
EP0210628A3 (en) * 1983-03-04 1989-02-08 The Ohio State University Antigenic modification of polypeptides
EP0178841A3 (en) * 1984-10-11 1987-05-27 University Of Southern California Intragonadal regulatory protein
US4780312A (en) * 1985-06-04 1988-10-25 National Institute Of Immunology Birth control vaccine
EP0326111A3 (en) * 1988-01-29 1989-12-27 New York Blood Center, Inc. Peptide derivatives rendered immunogenic when administered with alum as an adjuvant

Also Published As

Publication number Publication date
IN140169B (en:Method) 1976-09-25
IN140168B (en:Method) 1976-09-25
BE831786A (fr) 1975-11-17

Similar Documents

Publication Publication Date Title
GR3015791T3 (en) Synthetic peptides useful as universal carriers for the preparation of immunogenic conjugates and their use in the development of synthetic vaccines.
CA2006818A1 (en) Insulin derivatives, a process for the preparation thereof, the use thereof and a pharmaceutical formulation containing them
MY110665A (en) Combined vaccines comprising hepatitis b surface antigen and other antigen
ES8900006A1 (es) Un procedimiento para preparar un complejo de inmunogeno
ES8506451A1 (es) Procedimiento para preparar vacunas polivalentes adsorbidas y liofilizadas
GB1492445A (en) Immunochemically purified derivatives of human chorionic gonadotropin
IE42340L (en) 11,12-secoprostaglandins
AU497698B2 (en) Administering gas toa patient
GB1531014A (en) Oil-free adjuvant composition
SE8204874L (sv) Farmaceutiska preparat, innefattande humant insulin och humant proinsulin
NO306762B1 (no) Anvendelse av lanolinderivater sammen med polyetylenglykoletere, blanding derav og transdermalt terapeutisk system
SE8204873L (sv) Farmaceutiska preparat, innefattande humant insulin och human c-peptid
GR3003355T3 (en) Nicorandil-containing preparation for injection
NO800724L (no) Fremgangsmaate til fremstilling peptider med ubiquitinlignende aktivitet
AU525695B2 (en) Pharmaceutical formulations of prostacyclin
KR890008171A (ko) 펩타이드 구조물, 이를 함유하는 면역원 및 수정율 억제에 있어서 이의 용도
EP0565146A3 (en) Use of a thioester for preparing pharmaceutical compositions for the treatment of ischemia and reperfusion syndromes
WO1995032286A3 (en) Immunogenic carcinoembryonic antigen and methods of use and production
IE42139L (en) 19-nor-testosterone di-ester
IE42932L (en) Isoindole derivatives.
IT1060502B (it) Procedimento per la preparazione di composizioni di nerofumo ad alto tenore di carbonio e basso tenore di impurita
AU554859B2 (en) Polymerized albumin vaccine
EP0367302A3 (en) Process for semi-synthesis of human insulin, water-soluble cross-linked achromobacter protease i for use therein and a process for preparing the same
JPS5365875A (en) Preparation of benzenesulfone amide derivs.
JPS523016A (en) Preparation of high-purity leucine

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee